Download FREE Report Sample
Download Free sampleAzilsartan API Market contains market size and forecasts of Azilsartan API in global, including the following market information:
Global Azilsartan API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Azilsartan API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Azilsartan API companies in 2022 (%)
The global Azilsartan API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
0.98 Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Azilsartan API include Hangzhou Longshine Bio-Tech, Jiangsu Zhongbang Pharmaceutical, Jiangxi Synergy Pharmaceutical, Zhuhai Rundu Pharmaceutical, Lunan Pharmaceutical, Zydus Takeda Healthcare, ChemWerth Inc, Metrochem API and Ami Lifesciences Private Limited, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Azilsartan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Azilsartan API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Azilsartan API Market Segment Percentages, by Purity, 2022 (%)
0.98
0.99
Others
Global Azilsartan API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Azilsartan API Market Segment Percentages, by Application, 2022 (%)
Medical Pharmaceutical
Scientific Research
Global Azilsartan API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Azilsartan API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Azilsartan API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Azilsartan API revenues share in global market, 2022 (%)
Key companies Azilsartan API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Azilsartan API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hangzhou Longshine Bio-Tech
Jiangsu Zhongbang Pharmaceutical
Jiangxi Synergy Pharmaceutical
Zhuhai Rundu Pharmaceutical
Lunan Pharmaceutical
Zydus Takeda Healthcare
ChemWerth Inc
Metrochem API
Ami Lifesciences Private Limited
Piramal Pharma Solutions
Alembic Pharmaceuticals Limited
Aurobindo Pharma Limited
Glenmark Pharmaceuticals
Kyongbo Pharmaceutical
Takeda Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy